Disease Domain | Count |
---|---|
Neoplasms | 4 |
Infectious Diseases | 1 |
Immune System Diseases | 1 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 7 |
Target |
Mechanism IKKε inhibitors [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism PDE3 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism PDK1 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
ZK 756326 ( CCR8 ) | HIV Infections More | Preclinical |
BX-320 ( PDPK1 ) | Neoplasms More | Preclinical |
BX-912 ( PDPK1 ) | Neoplasms More | Preclinical |
ZK-805412 ( factor Xa ) | Thrombosis More | Preclinical |
BX-517 ( PDPK1 ) | Neoplasms More | Preclinical |